Cargando…

Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study

BACKGROUND: One of the most frequent side effects of atypical antipsychotics is hyperprolactinemia (HPRL), and metformin or aripiprazole co-prescription is regarded as an effective therapy option for reducing prolactin (PRL) levels. However, whether either of the two drugs can reduce PRL levels in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuebing, Sun, Xianzhi, Li, Lu, Zeng, Kuan, Li, Yi, Gao, Yujun, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933920/ https://www.ncbi.nlm.nih.gov/pubmed/36816406 http://dx.doi.org/10.3389/fpsyt.2023.1124691

Ejemplares similares

Factors influencing prolactin levels in chronic long-term hospitalized schizophrenic patients with co-morbid type 2 diabetes mellitus
por: Zhu, Junhong, et al.
Publicado: (2022)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020)

Suicidal Behavior and Medication Adherence in Schizophrenic Patients
por: Warriach, Zain I, et al.
Publicado: (2021)

Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
por: Xiao, Jingmei, et al.
Publicado: (2021)

Association of Ishii test scores with pneumonia in stable schizophrenic subjects
por: Yang, Qin, et al.
Publicado: (2022)

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
por: Zhi, Pu, et al.
Publicado: (2018)

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)
por: Hanssens, Linda, et al.
Publicado: (2008)

Cannabis Use and Dependence among French Schizophrenic Inpatients
por: Lejoyeux, Michel, et al.
Publicado: (2014)

Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis
por: Olivares, José Manuel, et al.
Publicado: (2022)

Attentional Load Effects on Beta Oscillations in Healthy and Schizophrenic Individuals
por: Ghorashi, Shahab, et al.
Publicado: (2015)

The Experience of Insomnia in Patients With Schizophrenic Disorder: A Qualitative Study
por: Batalla-Martín, David, et al.
Publicado: (2022)

The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review
por: Muneer, Ather
Publicado: (2016)

Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole?
por: Chipchura, Danielle A., et al.
Publicado: (2018)

Hiccups induced by aripiprazole combined with sertraline in an adolescent with olfactory reference disorder: A case report
por: Li, Zhe, et al.
Publicado: (2022)

An Investigation of Factors Increasing the Risk of Aggressive Behavior among Schizophrenic Inpatients
por: Lejoyeux, Michel, et al.
Publicado: (2013)

Functional Status of Hypothalamic–Pituitary–Thyroid and Hypothalamic–Pituitary–Adrenal Axes in Hospitalized Schizophrenics in Shanghai
por: Zhu, Yuncheng, et al.
Publicado: (2020)

A Qualitative Study of Use of Mindfulness to Reduce Long-Term Use of Habit-Forming Prescription Drugs
por: Dundas, Ingrid, et al.
Publicado: (2020)

Association of the Synapse-Associated Protein 97 (SAP97) Gene Polymorphism With Neurocognitive Function in Schizophrenic Patients
por: Xu, Xusan, et al.
Publicado: (2018)

Positive Urine Morphine Test in a Chinese Patient Receiving Methadone Maintenance Treatment After Eating Hot Pot: A Case Report
por: Ma, Jun, et al.
Publicado: (2020)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Oculogyric Crisis Due to Aripiprazole Ingestion as a Suicide Attempt: A Case Report
por: Bafarat, Ammar, et al.
Publicado: (2023)

Cognitive Control Functions in Unipolar Major Depression with and without Co-Morbid Anxiety Disorder
por: Lyche, Pia, et al.
Publicado: (2010)

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models
por: Samsom, James N., et al.
Publicado: (2015)

Social Cognition in Schizophrenic Patients: The Effect of Semantic Content and Emotional Prosody in the Comprehension of Emotional Discourse
por: Brazo, Perrine, et al.
Publicado: (2014)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data
por: Tao, Hejian, et al.
Publicado: (2022)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
por: Du, Xin, et al.
Publicado: (2015)

Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review
por: Bougeard, Clémence, et al.
Publicado: (2021)

Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model
por: Li, Meng, et al.
Publicado: (2022)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qian, Li, et al.
Publicado: (2021)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Maintenance Therapy of Psychosis Spectrum Disorders in a Real-World Setting: Antipsychotics Prescription Patterns and Long-Term Benzodiazepine Use
por: Maric, Nadja P., et al.
Publicado: (2022)

Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients
por: Renn, Jenn-Huei, et al.
Publicado: (2010)

Co-Morbid Obsessive–Compulsive Disorder and Attention Deficit Hyperactivity Disorder: Neurobiological Commonalities and Treatment Implications
por: Cabarkapa, Sonja, et al.
Publicado: (2019)

Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020)

Case report: rTMS in combination with aripiprazole and sodium valproate for the maintenance treatment of rapid cycling bipolar disorder
por: Tao, Siyi, et al.
Publicado: (2023)

Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
por: Sanchez-Gistau, Vanessa, et al.
Publicado: (2023)

Chronic Alcohol Treatment-Induced GABA-Aα5 Histone H3K4 Trimethylation Upregulation Leads to Increased GABA-Aα5 Expression and Susceptibility to Alcohol Addiction in the Offspring of Wistar Rats
por: Zeng, Kuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dgnq3qf195i44jht34n01i3se6